Company intelligence / Profile preview

Bio Balance

New York, New York, USAbiobalance.com.tr ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

Bio Balance, Inc. is a small biotechnology research company founded in New York in 1993. The company's mission centers on bridging basic biomedical research with practical drug development applications, particularly through detailed study of drug-receptor interactions to improve pharmaceuticals. It collaborates with industry and academia but does not appear to have advanced clinical programs or commercialized products at this time.

Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

1 asset

Escherichia coli strain M17

Beyond the preview

Go deeper on Bio Balance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio Balance.

Explore the full profile